Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 12:06 AM ET

Healthcare Equipment and Supplies

Company Overview of ArthroCare Corporation

Company Overview

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products based on its Coblation technology in the Americas and internationally. It offers sports medicine products, including Coblation Wands that features disposable energy-based surgical wands for single patient use to treat shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and soft-tissue fixation products, such as knotless and traditional anchors for rotator cuff and labrum repairs in the shoulder and hip; screws for ligament reconstruction in the knee; and arthroscopic suture passers, as well as reusable hand-held instruments, procedural kits, and accessories. The company also provi...

7000 West William Cannon Drive

Building 1

Austin, TX 78735

United States

Founded in 1993

1,840 Employees





Key Executives for ArthroCare Corporation

Chief Technology Officer and Senior Vice President of Research & Development
Age: 57
Chief Regulatory Officer and Senior Vice President of Quality Systems & Assurance
Age: 53
Senior Vice President and General Manager of Sports Medicine Business
Age: 45
General Manager, Clinincal Trial Manager and General Manager of Research & Development
Senior Vice President and General Manager of ENT
Age: 53
Compensation as of Fiscal Year 2015.

ArthroCare Corporation Key Developments

Arthrex Serves Second Patent Infringement Lawsuit Against Smith & Nephew and ArthroCare

Arthrex has served a patent infringement lawsuit against Smith & Nephew and its wholly-owned subsidiary, ArthroCare Corp. in the Federal Court for the Eastern District of Texas, Marshall Division. The lawsuit, which is the second patent infringement lawsuit the company has filed against Smith & Nephew and ArthroCare, Corp, alleges two new counts of infringement relating to Arthrex’s knotless anchor technology sold throughout the world. The first lawsuit against Smith & Nephew and ArthroCare Corp. was filed in the same court on June 18, 2015 alleging 47 counts of infringement relating to 12 threx patents. The new lawsuit brings the total to 49 counts relating to the following 13 Arthrex patents: 9,179,907, 8,821,541, 8,801,755, 8,623,052, 8,343,186, 7,329,272, 7,322,986, 7,195,634, 6,875,216, 6,629,977, 6,511,499, 6,214,031, 5,993,451. The new lawsuit alleges that Smith & Nephew and ArthroCare Corp. infringed on these patents and is seeking an injunction and damages on their manufacturing and sale of various lines of implants, including SpeedScrew, SpeedLock, SpeedLock Hip, LabraLock P, MultiFix, BioRaptor Knotless, Footprint PK, TwinFix and Ultra suture anchors, which are sold by Smith & Nephew to compete with Arthrex’s PushLock and SwiveLock implants.

ArthroCare Corporation Announces Board Resignations

On May 29, 2014, ArthroCare Corporation completed the merger contemplated by the agreement and plan of merger dated as of February 2, 2014, by and among ArthroCare, Smith & Nephew Inc., Rosebud Acquisition Corporation and Smith & Nephew plc. Pursuant to the merger agreement, ArthroCare was acquired by Smith & Nephew through a merger of merger subsidiary with and into ArthroCare, with ArthroCare surviving the merger as a wholly-owned subsidiary of Smith & Nephew (Surviving Corporation). In connection with the merger, on May 29, 2014, the directors of merger subsidiary immediately prior to the effective time became the directors of the Surviving Corporation and each director of ArthroCare immediately prior to the effective time ceased his or her service as a director of ArthroCare. In connection therewith, each of David Fitzgerald, Christian P. Ahrens, Gregory A. Belinfanti, Barbara D. Boyan, Ph.D., James G. Foster, Terrence E. Geremski, Fabiana Lacerca-Allen, Tord B. Lendau and Peter L. Wilson resigned from ArthroCare’s board of directors.

ArthroCare Corporation(NasdaqGS:ARTC) dropped from NASDAQ Composite Index

ArthroCare Corporation will be removed from the NASDAQ Composite Index.

Similar Private Companies By Industry

Company Name Region
Perceptive Navigation LLC United States
SpineSelect, LLC United States
Heartview, LLC United States
Fixes-4-Kids, Inc. United States
Sentient Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ArthroCare Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at